The effect of N-acetylcysteine in patients with non-cystic fibrosis bronchiectasis (NINCFB): study protocol for a multicentre, double-blind, randomised, placebo-controlled trial
Yue Liao(The University of Texas at Arlington), Jun Chen(South China Agricultural University), Hui Zhou(Shanghai International Studies University), Shuguan Xiong(Chengdu Medical College), Mei Chen(Guilin Medical University), Tao Wang(Heilongjiang University of Chinese Medicine), Fuqiang Wen(Sichuan University), Wei‐Ming Li(Kaohsiung Medical University), Lin Liu(Heilongjiang University of Chinese Medicine), Yanqiu Wu, Jiangyue Qin(Sichuan University), Yongchun Shen(Sichuan University), Lei Chen(Sichuan University), Kai Zi(Sichuan University)
Cited by 4
Related Papers
Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study
|The Lancet|2018|1.8k
Prevalence, risk factors, and management of asthma in China: a national cross-sectional study
|The Lancet|2019|773
The Multifaceted Therapeutic Role of N-Acetylcysteine (NAC) in Disorders Characterized by Oxidative Stress
|Current Neuropharmacology|2020|283
Resolvin D1 attenuates inflammation in lipopolysaccharide-induced acute lung injury through a process involving the PPARγ/NF-κB pathway
|Respiratory Research|2012|147
Up-regulation of gastric cancer cell invasion by Twist is accompanied by N-cadherin and fibronectin expression
|Biochemical and Biophysical Research Communications|2007|141